Date Title PDF
December 02, 2024 08:00 Interactions with UK Regulatory Authorities pdf
Date December 02, 2024 08:00
Title Interactions with UK Regulatory Authorities
PDF pdf
November 27, 2024 07:00 Positive Phase 2 Interim Results from BEXMAB Trial ● pdf
Date November 27, 2024 07:00
Title Positive Phase 2 Interim Results from BEXMAB Trial ●
PDF pdf
November 11, 2024 07:00 Targeting Soluble Clever-1 for Autoimmune Diseases pdf
Date November 11, 2024 07:00
Title Targeting Soluble Clever-1 for Autoimmune Diseases
PDF pdf
November 05, 2024 07:00 Shareholders’ Nomination Board ● pdf
Date November 05, 2024 07:00
Title Shareholders’ Nomination Board ●
PDF pdf
October 22, 2024 07:00 Faron’s Capital Markets Day 2024 pdf
Date October 22, 2024 07:00
Title Faron’s Capital Markets Day 2024
PDF pdf
October 07, 2024 07:00 Faron announces Capital Markets Day pdf
Date October 07, 2024 07:00
Title Faron announces Capital Markets Day
PDF pdf
August 30, 2024 07:00 Grant of options pdf
Date August 30, 2024 07:00
Title Grant of options
PDF pdf
August 27, 2024 07:00 FDA Grants Fast Track Designation for Bexmarilimab pdf
Date August 27, 2024 07:00
Title FDA Grants Fast Track Designation for Bexmarilimab
PDF pdf
August 27, 2024 07:00 Faron 2024 Half-Year Financial Results ● pdf
Date August 27, 2024 07:00
Title Faron 2024 Half-Year Financial Results ●
PDF pdf
August 20, 2024 07:00 Notice of Half-Year Financial Results ●● pdf
Date August 20, 2024 07:00
Title Notice of Half-Year Financial Results ●●
PDF pdf
Page: 1 of 53 ( 529 results)